V. Complicações após transplante cardíaco

Arquivos Brasileiros de Cardiologia

Volumn 73, Issue SUPPL. 5, 1999, Pages 27-37

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; BENZNIDAZOLE; CEFAZOLIN; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIBODY; DAPSONE; FLUCONAZOLE; FOLINIC ACID; GANCICLOVIR; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; NIFURTIMOX; OKT 3; PENTAMIDINE; PSEUDOMONIC ACID; PYRIMETHAMINE; STREPTOCOCCUS VACCINE; TIABENDAZOLE; VACCINE; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ASPERGILLOSIS; CANDIDIASIS; CARDIOLOGY; CHAGAS DISEASE; CYTOMEGALOVIRUS INFECTION; DYSLIPIDEMIA; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; IMMUNIZATION; INFECTIOUS COMPLICATION; KIDNEY FAILURE; LYMPHOPROLIFERATIVE DISEASE; MEDICAL SOCIETY; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE COMPLICATION; SHORT SURVEY; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TOXOPLASMA GONDII; TOXOPLASMOSIS; TRYPANOSOMIASIS; ARTICLE; BACTERIAL INFECTION; IMMUNOLOGY; MICROBIOLOGY; POSTOPERATIVE CARE; PRACTICE GUIDELINE; SURGICAL INFECTION;

BACTERIAL INFECTIONS; CHAGAS DISEASE; HEART TRANSPLANTATION; HUMANS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; SURGICAL WOUND INFECTION;

EID: 0042406769     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. World Health Organization - Control of Chagas Disease. Report a WHO Expert Committee. Geneva - WHO Techinical Report Series 1991; 811: 1-95.
2. Almeida, DR. Transplante cardíaco no tratamento da miocardiopatia chagásica (Tese Doutorado). São Paulo: Universidade Federal de São Paulo, 1996.
3. Almeida DR, Carvalho ACC, Branco JN, et al. Chagas disease reactivation after heart transplantation: Eficacy of allopurinol treatment. J Heart Lung Transplant 1996; 15: 988-92.
4. Bocchi EA, Bellotti G, Uip DE, et al. Long-term follow-up after heart transplantation in Chagas' disease. Transplantation Proc 1993; 25: 1329-30.
5. Chiar E, Dias JCP, Lana M, et al. Hemocultures for the parasitological diagnosis of human chronic Chagas' disease. Rev Soc Bras Med Trop 1989; 22: 19-23.
6. Bronfen E, Rocha FSA, Machado GBN, et al. Isolamento de amostras do Trypanosoma cruzi por xenodiagnóstico e hemoculture de pacientes na fase crônica da doença de Chagas. Mem Inst Oswaldo Cruz 1989; 84: 237-40.
7. Barbosa AJA. Método imunohistoquímico para identificação de amastigotas do Trypanosoma cruzi em cortes histológicos de rotina. Rev Inst Med Trop São Paulo 1985; 27: 293-7.
8. Higushi ML, Gutierrez PS, Aiello VD, et al. Imunohistochemical caracterization of infiltrating cells in human chronic chagasic myocarditis: comparasion with myocardial rejection process. Virchows Arch Pathol Anat 1993; 423: 157-60.
9. Miller LW, Naftel DC, Bourge RC, et al and the Cardiac Transplant Research Database Group. Infection after heart transplantation: a multiinstitutional study. J.Heart Lung Transplant 1994; 13: 381-92.
10. Uip DE, Amato Neto VA, Strabelli TMV, et al. Infecções em 100 pacientes submetidos a transplante cardíaco. Arq Bras Cardiol 1995; 64: 537-40.
11. Camargo LFA, Uip DE. Infecções em pacientes submetidos a transplante cardíaco. Rev Soc Cardiol ESP 1995; 5.
12. Campbell DC. Hospital-aquired Pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy and preventive strategies: a consensus statement. Am J Resp Crit Care Med 1995; 153: 171-87.
13. Fagon, Jy; Chastre, J.; Hance, Aj, Et al. Detection of nosocomial lung infection ventilated patients: use of a protected specimen brush and quantitative culture techniques in 147 patients. Am Respir Dis 138: 110-116, 1988
14. Meduri GU, Wunderink RG, Leeper KV, et al. Management of bacterial pneumonia in ventilated patients. Protected broncoalveolar lavage as a tool for diagnosing pneumonia in ventilated patients. Chest 1992; 101: 500-6.
15. Tablan OC, Anderson LJ, Arden NH, et al. Guideline for the prevention of nosocomial pneumonia. Infec Control Hosp Epidemiol 1994; 15: 587-627.
16. Camargo LFA, Strabelli TMV, Uip DE. Nosocomial Primary bacteremia:clinical and laboratory characteristics in adults and children. Braz J Infectious Dis 1998; 2: 31-6.
17. Hierholzer WH, et al. CDC guideline for prevention of intra-vascular device related infections. AJIC 1996; 24: 262-93.
18. Siegma-Igra Y, Anglim AM, Shapiro DE, Adal KA, Strain BA, Farr BM. Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis. J Clin Microbiol 1997; 35: 928-36.
19. Prevosti LG, Subramainian VA, Rothaus KO, Dineen P. A comparison of the open and closed methods in the initial treatment of sternal wound infections. J Cardiovasc Surg 1989; 30: 757-63.
20. Kangro HO, Booth JC, Bakir TMF, Tryhorn Y, Sutherland S. Detection of IgM antibodies against cytomegalovirus: comparison of two radioimmunoassays, enzyme-linked immunoabsorbent assay ans immunofluorescent antibody test. J Med Virol 1982; 10: 203-12.
21. Gleaves CA, Smith TF, Shuster EA, Pearson GR. Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol 1985; 21: 217-21.
22. Tanabe K, Tokumoto T, Ishikawa N, et al. Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology and the shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation. Transplantation 1997; 64: 17-21.
23. Koskinem PK, Nieminem MS, Mattila SP, Hayry Lautenshlager IT. The correlation between symptomatic CMV infection and CMV antigenemia in heart allograft recipients. Transplantation 1993; 55: 547-51.
24. Gerna G, Zipeto D, Parea M, et al. Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia and DNAemia. J Infect Dis 1991; 163: 488-98.
25. Palel R, Paya CV. Infection in solid-organ transplant recipients. Clin Microbiol Ver 1997; 10: 86-124.
26. Kirklin JK, Naftel DC, Levine TB, et al. and the Cardiac transplant research database group. J Heart Lung Transplant 1994; 13: 394-404.
27. Reed EC, Bowden RA, Dandliker PS. Treatment of cylomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Int Med 1988; 109: 738-88.
28. Wreghitt TG, Gray JJ, Pavel P, et al. Efficacy of pyrimethamine for the prevention of donor-acquired Toxoplasma gondii infection in heart and heart-lung transplant patients. Transpl Int 1992; 5: 197-200.
29. Rassi A, Luquetti AO. Therapy of Chagas' Disease. In: Wendel S, Brener Z, Camargo MF, Rassi A (eds) - Chagas' Disease (American Trypanosomiasis): His Impact on Transfusion and Clinical Medicine. Brazil: Cartgraf Editora Ltda. 1992: 237-47.
30. Fragata FAA. Tratamento etiológico da doença de Chagas. In: SOCESP Cardiologia. São Paulo: Ateneu 1996; 2: 598-607.
31. Amato Neto V. Terapêutica da forma crônica da doença de Chagas. Tratamento específico da infecção pelo Trypanosoma cruzi. Arq Bras Cardiol 1998; 70: 63-4.
32. a ed. Brasília. 1997: 1-32.
33. Andrade SG, Stocker-Guerret S, Pimentel AS, Grimaldi JA. Reversibility of cardiac fibrosis in mice chronically infected with Trypanosoma cruzi under specific chemoterapy. Mem Inst Oswaldo Cruz 1991; 86: 187-200.
34. Stolf NAG, Higushi ML, Bocchi EA, et al. Heart transplantation in patients with Chagas' disease cardiomyopathy. J Heart Transplant 1987; 6: 307-12.
35. Carvalho VB, Souza EFL, Vila JHA, et al. Heart transplantation in Chagas' disease: 10 years after the initial experience. Circulation 1996; 94: 1815-17.
36. Rassi A, Amato Neto V, Siqueira AF, et al. Influência de corticóide na doença de Chagas crônica, administrado em virtude de afecçães associadas. Rev Soc Br Med Tropical 1997; 30: 93-9.
37. Rassi A, Amato Neto V, Siqueira AF, Leite BMS. Efeito protetor do nifurtimox contra a reativação parasitária em pacientes cronicamente infectados pelo Trypanosoma cruzi e tratados com corticóide em virtude de afecçães associadas. Rev Soc Br Med Tropical 1998; 31: 249-55.
38. Tominori YJ, Deps PD, Almeida DR, Enokihara MM, de Seixas MT, Freymüller E. Cutaneous manifestation of Chagas' disease after heart transplantation: successfull treatment with allopurinol. Br J Dermatol 1997; 137: 626-30.
39. Andrade ALSS, Zicker F, Oliveira RM, et al. Randomised trial of efficacy of benzonidazole in treatment of early Trypanosoma cruzi infection. Lancet 1996; 348: 1407-13.
40. Viotti R, Viglano C, Armenti H, Segura E. Treatment of chronic Chagas disease with benzonidazole: clinical and serological evolution of patients with long-term follow-up. Am Heart J 1994; 127: 151-62.
41. Coura JR, Abreu LL, Percy H, Wilcox F, Pestana W. Estudo comparativo controlado com emprego de benzonidazole. nifurtimox e placebo, na forma crônica da doença de Chagas, em uma área de campo com transmissão interrompida. I-Avaliação preliminar. Rev Soc Bras Med Tropical 1997; 30: 139-44.
42. Zingales B, Pereira MES, Oliveira RP, et al. Trypanosoma cruzi genoma project: biological characteristics and molecular typing of clone CL Brener. Acta Tropica 1997; 68: 159-73.
43. Nalesmek MA, Nakomka L, Starzl TE. The diagnosis and treatment of post transplant lymphoproliferotive disorders. Ann Probl Surg 1998: 367-472.
44. Klein G. Tumor immunology. Transpl. Proc 1973: 531-4.
45. Boon T, et al. Tumor antigens recognized by T lymphocytes. Annual Review of Immunology 1994; 12: 337-66.
46. Penn I. Neoplastic consequences of immunosupression. In: Dean JH. Ed - Immunotoxicology and Immunopharmacology. New York: Raven Press. 1985.
47. Euvrad S, et al Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after Kidney and Heart transplantation. J Am Acad Dermatol 1995; 33: 222-9.
48. Lampros TD, et al. Squamous and basal cell carcinoma in heart transplant recipients. J Heart Lung Transplant 1998; 17: 586-91.
49. Curtil, et al. Malignant neoplasms following cardiac transplantantion. Eur J Cardiothoracic Surg 1997; 12: 101-6.
50. Taniguchi S, et al: Primary bronchogenic carcinoma in recipients of heart transplants. Transpl Int 1997; 10: 312-6.
51. Swinnen, et al. Increased incidence of lymphoproliferative disorder after imunosupression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 1990; 323: 1723-8.
52. Ternesten-Beatel A, et al. Specific expression of E-B virus in cutaneous squamous cell carcinomas from heart transplant recipients. Transplantation 1988; 66: 1524-9.
53. Goldstein DJ, et al. De novo solid malignancies after cardiac transplantation. Ann Thoracic Surg 1995; 60: 1783-9.
54. Heneros J, et al. Enfermedad linfoproliferativa e cancer en el transplantado. Rev Esp Cardiol 1995; 48(suppl 7): 129-34.
55. Chadburn A. The morphological and genetic categories of post transplantation lymphoproliferative disorders are clinically relevant. Cancer 1998; 82: 1978-87.
56. Milhacov MI, et al. Incidence of post-transplant malignancy among 674 solid, organ, transplant recipientes at a single center. Clin Transpl 1996; 10: 248-55.
57. Pham, et al. Solid tumous after heart transplantation: lethality of lung cancer. Ann Thoracic Surg 1995; 60: 1623-6.
58. Espanã A, et al. Skin cancer in heart transplant recipients. J Am Acad Dermatol 1995; 32: 458-65.
59. Goldstein DS, et al. Carcinoma of the lung after transplantation. 1996; 62: 772-5.
60. Hannson G, et al. Cutaneous complications in heart transplant recipients in Norway 1983-1993. Acta Derm Venereol 1995; 745: 400-3.
61. Van Gelder T, Balk AH, Zietse R, et al. Renal insufficiency after heart transplantation: a case-control study. Nephrol Dial Transplant 1998; 13: 2322-6.
62. Ventura HO, Malik FS, Mehra MR, et al. Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine. Curr Opin Cardiol 1997; 12: 375-81.
63. III Consenso Brasileiro de Hipertensão Arterial, Campos do Jordão, SP - 1998.
64. Valantine HA. Long-term management and results in heart transplant Recipients. Cardiology Clinics 1990; 8: 141-8.
65. Augustim: SM, Baumgartner WA, Kasper EK. Obesity and hypercholesterolemia followins heart transplantation. J Transpl Coord 1998; 8: 164-9.
66. Gohlke HC, Gohlke-Bärwolf. Cardiac rehabilitation. Eur Heart Journal 1998; 19: 1004-10.
67. Thompson DR, Bowman GS, Kitson AL, Bono DP, Hopkins A. Cardiac rehabilitation in the United Kingdom: guidelinaes and audit standards. Heart 1996; 75: 89-93.
68. Squires RW. Exercise training after cardiac transplantation. Med Sci Sports Exerc 1991; 23: 686-94.
69. Ferraz AS, Arakaki H, Atividade física e qualidade de vida após transplante cardíaco. Rev Soc Cardiol ESP 1995; 5: 670-8.
70. a ed. Sarvier-APM: São Paulo, 1994: 201-9.
71. Kobashigawa JA, Leaf DA, Lee N, et al. A controlled trial of exercise rehabilitation after heart transplantation. N Engl J Med 1999; 340: 272-7.
72. Lampert E, Mettauer B.,Hoppeler H, et al. Skeletal muscle reponse to short endurance training in heart transplant recipients. J Am Coll Cardiol 1998; 32: 420-6.
73. McCartney N. Role of resistance training in heart disease. Med Sci Sports Exerc 1998; 30: S396-402.
74. Joshi A, Kevorkian CG. Rehabilitation after transplantation. Am J Phys Med Rehabil 1997; 76: 249-54.
75. Carrel T, Mohacsi P. Optimal timing of rehabilitation after cardiac surgery: the surgeon's view. Eur Heart J 1998; (suppl O): 38-41.
76. Young JB, Winters WL, Bourge R, Uretsky BE. Task Force 4: Function of the transplanted heart. J Am Coll Cardiol 1993; 22: 31-41.
77. Bocchi EA. Transplante cardíaco em portadores da cardiopatia chagásica. Rev Soc Cardiol ESP 1994; 2: 198-204.
78. Giorgi DMA, Bortolotto LA, Bocchi EA, et al. Twenty-four-hour monitoring for blood and heart rate in ehart transplant patients. J Hypertension 1991; 9: 340-1.
79. Bocchi EA, Bellotti G, Mocelin A, et al. Heart transplantation for chronic Chagas' heart disease. Ann Thorac Surg 1996; 61: 1727-33.
80. Bocchi EA, Huguchi ML, Vieira MC, et al. Higher inicidence of malignant neoplasms after heart transplantation for treatment for chronic Chagas' heart disease. J Heart Lung Transplant 1998; 17: 399-405.